nmbr1stckpckr wrote: Do you think the Company sho
Post# of 148170
Do you think the Company should have done more to get their 4 doses and IV injection when they discussed the CD12 protocol with the EFFDA? Do you think the Company could have forced their position thru the EFFDA's opposition?
response:
YES!!! This topic is a major influence upon my thinking that the FDA "is in cahoots" with BP, attempting to cripple Leronlimab. Dr Bruce Patterson said during our eIND cases in early 2020, that we did regularly, not always, give 3 or 4 shots to the critical covid19 patients. Then we've read that Cytodyn requested a 3rd and 4th shot protocol for our s/c trial, but the FDA said no. When asked, Nader refused to blame the FDA suspiciously IMO. Then, no Primary Endpoint met. If 3rd & 4th shots applied, a couple hundred thousand US folks alive today and EUA and stock at $60/share. This is accurate, truth, reality, no hype, no pump. I read everything all day everyday. I'm not a virologist nor a biologist, but training/ed in chemistry helps me to get the bottom line.